According to Bellerophon Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 12,232,648. At the end of 2023 the company had 12,232,648 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 12.23 M | 28.15% |
2022 | 9.54 M | 0.41% |
2021 | 9.5 M | 0.16% |
2020 | 9.49 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | 1,734,076,358 | 14,075.81% | ๐บ๐ธ USA |
Baxter BAX | 507,000,000 | 4,044.65% | ๐บ๐ธ USA |
Lantheus Holdings LNTH | 68,436,000 | 459.45% | ๐บ๐ธ USA |
Abeona Therapeutics
ABEO | 24,797,564 | 102.72% | ๐บ๐ธ USA |